These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15714418)

  • 1. Economic access to effective drugs for falciparum malaria.
    Panosian CB
    Clin Infect Dis; 2005 Mar; 40(5):713-7. PubMed ID: 15714418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A global subsidy for antimalarial drugs.
    Gelband H; Seiter A
    Am J Trop Med Hyg; 2007 Dec; 77(6 Suppl):219-21. PubMed ID: 18165495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluation of a policy change from single-agent treatment for suspected malaria to artesunate-amodiaquine for microscopically confirmed uncomplicated falciparum malaria in the Oussouye District of south-western Senegal.
    Agnamey P; Brasseur P; Cisse M; Gaye O; Dumoulin J; Rigal J; Taylor WR; Olliaro P
    Trop Med Int Health; 2005 Sep; 10(9):926-33. PubMed ID: 16135201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of modulators in Plasmodium falciparum resistance to antimalarials].
    Verdier F; Pussard E
    Med Trop (Mars); 1995; 55(4 Suppl):27-32. PubMed ID: 8649262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artemisinin-based combination treatment of falciparum malaria.
    Nosten F; White NJ
    Am J Trop Med Hyg; 2007 Dec; 77(6 Suppl):181-92. PubMed ID: 18165491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artemisinin-based combination therapy for uncomplicated malaria in sub-Saharan Africa: the efficacy, safety, resistance and policy implementation since Abuja 2000.
    Ogbonna A; Uneke CJ
    Trans R Soc Trop Med Hyg; 2008 Jul; 102(7):621-7. PubMed ID: 18499204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
    Kolaczinski K; Durrani N; Rahim S; Rowland M
    Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1081-7. PubMed ID: 17707447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of falciparum malaria in the age of drug resistance.
    Shanks GD
    J Postgrad Med; 2006; 52(4):277-80. PubMed ID: 17102546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
    Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Malaria therapy in the era of chloroquine resistance].
    Mordmüller B; Graninger W; Kremsner PG
    Wien Klin Wochenschr; 1998 May; 110(9):321-5. PubMed ID: 9629623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should new antimalarial drugs be subsidized?
    Laxminarayan R; Parry IW; Smith DL; Klein EY
    J Health Econ; 2010 May; 29(3):445-56. PubMed ID: 20381182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A network to monitor antimalarial drug resistance: a plan for moving forward.
    Sibley CH; Barnes KI; Watkins WM; Plowe CV
    Trends Parasitol; 2008 Jan; 24(1):43-8. PubMed ID: 18042432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Putting the genie back in the bottle? Availability and presentation of oral artemisinin compounds at retail pharmacies in urban Dar-es-Salaam.
    Kachur SP; Black C; Abdulla S; Goodman C
    Malar J; 2006 Mar; 5():25. PubMed ID: 16569252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current antimalarial drugs: resistance and new strategies].
    Ringwald P
    Bull Acad Natl Med; 2007 Oct; 191(7):1273-84; discussion 1284. PubMed ID: 18447049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responding to the challenge of antimalarial drug resistance by routine monitoring to update national malaria treatment policies.
    Vestergaard LS; Ringwald P
    Am J Trop Med Hyg; 2007 Dec; 77(6 Suppl):153-9. PubMed ID: 18165488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!
    Mutabingwa TK
    Acta Trop; 2005 Sep; 95(3):305-15. PubMed ID: 16098946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A global subsidy: key to affordable drugs for malaria?
    Laxminarayan R; Gelband H
    Health Aff (Millwood); 2009; 28(4):949-61. PubMed ID: 19597193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana.
    Koram KA; Abuaku B; Duah N; Quashie N
    Acta Trop; 2005 Sep; 95(3):194-203. PubMed ID: 16054584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pricing, distribution, and use of antimalarial drugs.
    Foster SD
    Bull World Health Organ; 1991; 69(3):349-63. PubMed ID: 1893512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.